Jazz Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
CEORenée D. Galá
CEORenée D. Galá
Employees2,800
Employees2,800
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2005
Founded2005
Employees2,800
Employees2,800
JAZZ Key Statistics
Market cap10.31B
Market cap10.31B
Price-Earnings ratio-27.95
Price-Earnings ratio-27.95
Dividend yield—
Dividend yield—
Average volume1.16M
Average volume1.16M
High today$171.47
High today$171.47
Low today$165.66
Low today$165.66
Open price$165.66
Open price$165.66
Volume801.30K
Volume801.30K
52 Week high$182.99
52 Week high$182.99
52 Week low$95.49
52 Week low$95.49
Stock Snapshot
As of today, Jazz Pharmaceuticals(JAZZ) shares are valued at $169.67. The company's market cap stands at 10.31B, with a P/E ratio of -27.95.
On 2025-12-22, Jazz Pharmaceuticals(JAZZ) stock moved within a range of $165.66 to $171.47. With shares now at $169.67, the stock is trading +2.4% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 801.3K, compared to an average daily volume of 1.16M.
Over the past 52 weeks, Jazz Pharmaceuticals(JAZZ) stock has traded between a high of $182.99 and a low of $95.49.
Over the past 52 weeks, Jazz Pharmaceuticals(JAZZ) stock has traded between a high of $182.99 and a low of $95.49.
Analyst ratings
89%
of 18 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.